Ten-year survival of patients treated with peritoneal dialysis: A prospective observational cohort study. 2020

Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
196531Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.

Few studies evaluated over 5-year outcomes of dialysis patients. This study examined 10-year all-cause mortality and death-censored technique failure in a cohort of incident peritoneal dialysis (PD) individuals. Five hundred and thirty-three incident PD individuals from 2006 to 2008 were prospectively followed up for more than 10 years until 2018. Clinical characteristics at PD initiation were collected. The primary outcome was all-cause mortality, and the secondary outcome was death-censored technique failure. Cox hazards models were fit using clinical characteristics at PD initiation. The mean age starting PD for these participants was 48 ± 16 years; 130 (24%) patients had diabetic nephropathy. During follow-up, 208 patients died, and 84 patients experienced technique failures. The 1, 3, 5, and 10 years' survival rates for incident PD patients were 93%, 81%, 64%, and 36%, respectively, and the technical survival rates were 98%, 93%, 85%, and 62%, respectively. Mortality risk was much higher after 3 years on PD. The peritonitis rate was 0.19 episodes per patient-year, and 7 (1.3%) patients had encapsulating peritoneal sclerosis (EPS) giving an incidence rate of 3.1 of 1000 patient-years. The main causes of death were cardiovascular events (97 of 208, 47%), and technique failure was mainly due to peritonitis (41 of 84, 49%). Older age, higher Charlson comorbidity index, and lower level of education were strongly associated with mortality, and diabetic nephropathy was an independent risk factor for technique failure. The 10-year's survival and technique survival rates of incident PD patients were 36% and 62%. Long-term PD can be continued successfully with improved outcomes and low risk for EPS.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
April 2010, Journal of thrombosis and haemostasis : JTH,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
January 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
May 2023, Clinical and experimental nephrology,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
April 2024, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
May 2022, Seminars in dialysis,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
March 2019, Scientific reports,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
January 2012, PloS one,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
August 2018, The British journal of nutrition,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
April 2022, Clinical and experimental nephrology,
Xi Xia, and Yagui Qiu, and Jing Yu, and Tong Lin, and Miaoqing Lu, and Chunyan Yi, and Jianxiong Lin, and Hongjian Ye, and Wei Chen, and Haiping Mao, and Xiao Yang, and Fengxian Huang
February 2024, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!